Tratamiento de la glomerulonefritis lúpica proliferativa difusa con ciclofosfamida por vía intravenosa. Experiencia en 11 pacientes
F. Santa Cruz, D. Cuevas, S. Barreto, M. Mayor y N. Breuer
Leído
4191
Vecesse ha leído el artículo
2006
Total PDF
2185
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 7 | 22 | 14 | 36 |
| 2025 6 | 116 | 150 | 266 |
| 2025 5 | 62 | 28 | 90 |
| 2025 4 | 43 | 24 | 67 |
| 2025 3 | 70 | 49 | 119 |
| 2025 2 | 51 | 39 | 90 |
| 2025 1 | 31 | 54 | 85 |
| 2024 12 | 25 | 21 | 46 |
| 2024 11 | 33 | 54 | 87 |
| 2024 10 | 35 | 33 | 68 |
| 2024 9 | 34 | 21 | 55 |
| 2024 8 | 67 | 39 | 106 |
| 2024 7 | 48 | 30 | 78 |
| 2024 6 | 30 | 28 | 58 |
| 2024 5 | 36 | 35 | 71 |
| 2024 4 | 26 | 30 | 56 |
| 2024 3 | 18 | 16 | 34 |
| 2024 2 | 23 | 32 | 55 |
| 2024 1 | 17 | 31 | 48 |
| 2023 12 | 16 | 18 | 34 |
| 2023 11 | 19 | 30 | 49 |
| 2023 10 | 22 | 29 | 51 |
| 2023 9 | 17 | 22 | 39 |
| 2023 8 | 18 | 20 | 38 |
| 2023 7 | 19 | 25 | 44 |
| 2023 6 | 29 | 20 | 49 |
| 2023 5 | 20 | 25 | 45 |
| 2023 4 | 11 | 23 | 34 |
| 2023 3 | 12 | 17 | 29 |
| 2023 2 | 10 | 13 | 23 |
| 2022 1 | 20 | 23 | 43 |
| 2022 12 | 16 | 30 | 46 |
| 2022 11 | 27 | 24 | 51 |
| 2022 10 | 34 | 49 | 83 |
| 2022 9 | 25 | 34 | 59 |
| 2022 8 | 15 | 22 | 37 |
| 2022 7 | 23 | 33 | 56 |
| 2022 6 | 23 | 30 | 53 |
| 2022 5 | 31 | 22 | 53 |
| 2022 4 | 22 | 40 | 62 |
| 2022 3 | 24 | 39 | 63 |
| 2022 2 | 21 | 39 | 60 |
| 2021 1 | 23 | 29 | 52 |
| 2021 12 | 20 | 41 | 61 |
| 2021 11 | 28 | 37 | 65 |
| 2021 10 | 28 | 31 | 59 |
| 2021 9 | 33 | 26 | 59 |
| 2021 8 | 24 | 28 | 52 |
| 2021 7 | 26 | 24 | 50 |
| 2021 6 | 14 | 19 | 33 |
| 2021 5 | 15 | 8 | 23 |
| 2021 4 | 25 | 20 | 45 |
| 2021 3 | 24 | 18 | 42 |
| 2021 2 | 32 | 17 | 49 |
| 2020 1 | 13 | 9 | 22 |
| 2020 12 | 19 | 11 | 30 |
| 2020 11 | 15 | 5 | 20 |
| 2020 10 | 14 | 10 | 24 |
| 2020 9 | 13 | 8 | 21 |
| 2020 8 | 8 | 5 | 13 |
| 2020 7 | 17 | 12 | 29 |
| 2020 6 | 13 | 5 | 18 |
| 2020 5 | 19 | 16 | 35 |
| 2020 4 | 23 | 16 | 39 |
| 2020 3 | 4 | 9 | 13 |
| 2020 2 | 9 | 19 | 28 |
| 2020 1 | 10 | 11 | 21 |
| 2019 12 | 7 | 14 | 21 |
| 2019 11 | 9 | 4 | 13 |
| 2019 10 | 4 | 3 | 7 |
| 2019 9 | 8 | 31 | 39 |
| 2019 8 | 9 | 9 | 18 |
| 2019 7 | 4 | 17 | 21 |
| 2019 6 | 2 | 10 | 12 |
| 2019 5 | 10 | 33 | 43 |
| 2019 4 | 42 | 50 | 92 |
| 2019 3 | 3 | 7 | 10 |
| 2019 2 | 12 | 5 | 17 |
| 2019 1 | 14 | 8 | 22 |
| 2018 12 | 10 | 17 | 27 |
| 2018 11 | 3 | 2 | 5 |
| 2018 10 | 5 | 0 | 5 |
| 2018 9 | 4 | 0 | 4 |
| 2018 8 | 2 | 0 | 2 |
| 2018 7 | 0 | 1 | 1 |
| 2018 6 | 2 | 0 | 2 |
| 2018 5 | 1 | 0 | 1 |
| 2018 4 | 0 | 0 | 0 |
| 2018 3 | 1 | 0 | 1 |
| 2017 12 | 3 | 0 | 3 |
| 2017 10 | 3 | 0 | 3 |
| 2017 8 | 3 | 0 | 3 |
| 2017 7 | 1 | 1 | 2 |
| 2017 6 | 1 | 2 | 3 |
| 2017 5 | 2 | 1 | 3 |
| 2017 4 | 4 | 0 | 4 |
| 2017 3 | 3 | 0 | 3 |
| 2016 1 | 1 | 0 | 1 |
| 2016 12 | 3 | 0 | 3 |
| 2016 10 | 15 | 1 | 16 |
| 2016 9 | 3 | 0 | 3 |
| 2016 8 | 21 | 0 | 21 |
| 2016 7 | 19 | 1 | 20 |
| 2016 6 | 37 | 0 | 37 |
| 2016 5 | 24 | 0 | 24 |
| 2016 4 | 24 | 0 | 24 |
| 2016 3 | 7 | 0 | 7 |
| 2016 2 | 4 | 0 | 4 |
| 2015 1 | 11 | 0 | 11 |
| 2015 12 | 15 | 0 | 15 |
| 2015 11 | 13 | 0 | 13 |
| 2015 10 | 9 | 0 | 9 |
| 2015 9 | 12 | 0 | 12 |
| 2015 8 | 9 | 0 | 9 |
| 2015 7 | 20 | 0 | 20 |
| 2015 6 | 6 | 0 | 6 |
| 2015 5 | 30 | 0 | 30 |
Mostrar todo
